文献速递胸部CT

新一代自适应统计迭代重建(ASIR-V)在低剂量胸部CT肺结节诊断中的临床价值

Clinical value of a new generation adaptive statistical iterative reconstruction (ASIR-V) in the diagnosis of pulmonary nodule in low-dose chest CT.
PubMed 文献 · Br J Radiol · 2019-09-06

30例肺结节患者行Revolution CT检查,标准剂量(噪声指数14)FBP重建,发现结节后行低剂量靶扫描(噪声指数24)60% ASIR-V重建。低剂量靶扫描检出87个结节中的85个(97.7%),2个<1 cm磨玻璃密度结节漏诊;结节大小、CT值、标准差、信噪比、对比噪声比及主观评分与标准剂量FBP图像均无差异(均P>0.05)。全肺虚拟低剂量有效剂量1.44±0.15 mSv,较标准剂量扫描降低59.1%。

要点

  • 低剂量靶扫描ASIR-V对肺结节总体检出率97.7%(85/87),漏诊2个<1 cm磨玻璃密度结节。
  • 低剂量ASIR-V与标准剂量FBP图像在结节大小、CT值、噪声及主观评分上均无显著差异(均P>0.05)。
  • 全肺虚拟低剂量有效剂量较标准剂量降低59.1%(1.44±0.15 mSv vs 3.52±1.09 mSv)。

核心结论

  • 低剂量CT联合ASIR-V算法在肺结节检出和显示方面与标准剂量FBP图像价值相当。

研究设计与样本

  • 30例肺结节患者行Revolution CT检查,先以噪声指数14行标准剂量全肺扫描并用FBP重建,发现结节后以噪声指数24行低剂量靶扫描并用60% ASIR-V重建,记录两种扫描模式的结节检出率、结节大小、CT值、标准差、信噪比、对比噪声比及两名有经验放射科医师的5分法主观评分,并记录容积CT剂量指数、剂量长度乘积和有效剂量。

关键影像表现/征象

  • 低剂量靶扫描检出87个肺结节中的85个,漏诊2个小于1 cm的磨玻璃密度结节,总体检出率97.7%。
  • 低剂量ASIR-V与标准剂量FBP图像结节大小分别为1.49±0.74 cm和1.48±0.75 cm,差异无统计学意义(P>0.05)。
  • 低剂量ASIR-V与标准剂量FBP图像结节CT值分别为33.02±1.95 HU和34.6±3.07 HU,差异无统计学意义(P>0.05)。
  • 低剂量ASIR-V与标准剂量FBP图像结节标准差分别为27.64±14.42 HU和30.38±20.04 HU,差异无统计学意义(P>0.05)。
  • 低剂量ASIR-V与标准剂量FBP图像信噪比分别为1.44±0.88和1.43±1.31,对比噪声比分别为38.95±18.43和38.23±14.99,差异均无统计学意义(P>0.05)。

诊断标准与关键数值

  • 标准剂量扫描噪声指数为14,图像采用FBP算法重建。
  • 低剂量靶扫描噪声指数为24,图像采用60% ASIR-V重建。
  • 主观图像质量采用5分法由两名有经验放射科医师评分,两种扫描模式主观评分无差异。

临床应用与阅片要点

  • 低剂量靶扫描ASIR-V对肺结节检出率与标准剂量FBP相当,可用于肺结节检出。
  • 小于1 cm的磨玻璃密度结节在低剂量靶扫描中可能漏诊(本研究中漏诊2个)。
  • 全肺虚拟低剂量有效剂量1.44±0.15 mSv,较标准剂量扫描3.52±1.09 mSv降低59.1%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the clinical value of low-dose chest CT combined with the new generation adaptive statistical iterative reconstruction (ASIR-V) algorithm in the diagnosis of pulmonary nodule.

METHODS: 30 patients with pulmonary nodules underwent chest CT using Revolution CT. The patients were first scanned with standard-dose at a noise index (NI) of 14, and the images were reconstructed with filtered back projection (FBP) algorithm. If pulmonary nodules were found, a low-dose targeted scan, with NI of 24, was performed localized on the nodules, and the images were reconstructed with 60% ASIR-V. The detection rate of pulmonary nodules in the two scanning modes was recorded. The size of nodules, CT value and standard deviation of nodules were measured. The signal-to-noise ratio and contrast-to-noise ratio were also calculated. Two experienced radiologists used a 5-point method to score the image quality. The volumetric CT dose index, and dose-length product were recorded and the effective dose (ED) was calculated of the two scanning modes.

RESULTS: Volumetric CT dose index (ED) of the standard-dose scan covering the entire lungs was 7.29 ± 2.38 mGy (3.52 ± 1.09 mSv), and that of low-dose targeted scan was 2.56 ± 1.87 mGy (0.51 ± 0.32 mSv). However, the ED of the virtual low-dose scan for the entire lungs was 1.44 ± 0.15 mSv, which would mean a dose reduction of 59.1% compared with the standard-dose scan. 85 of the 87 pulmonary nodules were detected in the low-dose targeted scan, with 2 of the ground-glass density nodules with size less than 1 cm missed, resulting in 97.7% overall detection rate. There was no difference between the low-dose ASIR-V images and standard-dose FBP images for the size (1.49 ± 0.74 cm vs 1.48 ± 0.75 cm), CT value [33.02 ± 1.95 Hounsfield unit (HU) vs 34.6 ± 3.07 HU], standard deviation (27.64 ± 14.42 HU vs 30.38 ± 20.04 HU), signal-to-noise ratio (1.44 ± 0.88 vs 1.43 ± 1.31) and contrast-to-noise ratio (38.95 ± 18.43 vs 38.23 ± 14.99) of nodules (all p > 0.05). There was no difference in the subjective scores between the two scanning modes.

CONCLUSION: The low-dose CT scan combined with ASIR-V algorithm is of comparable value in the detection and the display of pulmonary nodules when compared with the FBP images obtained by standard-dose scan.

ADVANCES IN KNOWLEDGE: This is a clinical study to evaluate the clinical value of pulmonary nodules using ASIR-V algorithm in the same patients in the low-dose chest CT scans. It suggests that ASIR-V provides similar image quality and detection rate for pulmonary nodules at much reduced radiation dose.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Tang H, Liu Z, Hu Z, et al. Clinical value of a new generation adaptive statistical iterative reconstruction (ASIR-V) in the diagnosis of pulmonary nodule in low-dose chest CT. Br J Radiol. 2019. PMID: 31469289. doi:10.1259/bjr.20180909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。